Literature DB >> 27531077

TNF activity and T cells.

Amit K Mehta1, Donald T Gracias1, Michael Croft2.   

Abstract

TNF (tumor necrosis factor) is both a pro-inflammatory and anti-inflammatory cytokine that is central to the development of autoimmune disease, cancer, and protection against infectious pathogens. As well as a myriad other activities, TNF can be a product of T cells and can act on T cells. Here we review old and new data on the importance of TNF produced by T cells and how TNF signaling via TNFR2 may directly impact alternate aspects of T cell biology. TNF can promote the activation and proliferation of naïve and effector T cells, but also can induce apoptosis of highly activated effector T cells, further determining the size of the pathogenic or protective conventional T cell pool. Moreover, TNF can have divergent effects on regulatory T cells. It can both downregulate their suppressive capacity, but also contribute in other instances to their development or accumulation. Biologics that block TNF or stimulate TNFR2 therefore have the potential to strongly modulate the balance between effector T cells and Treg cells which could impact disease in both positive and negative manners.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  T cells; TNF; TNFR1; TNFR2; Treg

Mesh:

Substances:

Year:  2016        PMID: 27531077      PMCID: PMC5305780          DOI: 10.1016/j.cyto.2016.08.003

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  73 in total

Review 1.  Therapeutic T-cell manipulation in rheumatoid arthritis: past, present and future.

Authors:  J D Isaacs
Journal:  Rheumatology (Oxford)       Date:  2008-05-25       Impact factor: 7.580

Review 2.  Regulation of autoimmunity by proinflammatory cytokines.

Authors:  A P Cope
Journal:  Curr Opin Immunol       Date:  1998-12       Impact factor: 7.486

3.  Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection.

Authors:  M Suresh; Anju Singh; Christopher Fischer
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 4.  Tumor necrosis factor-alpha-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules.

Authors:  Sudhir Gupta
Journal:  Exp Gerontol       Date:  2002 Jan-Mar       Impact factor: 4.032

5.  TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.

Authors:  Thomas Calzascia; Marc Pellegrini; Håkan Hall; Laurent Sabbagh; Nobuyuki Ono; Alisha R Elford; Tak W Mak; Pamela S Ohashi
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

6.  TNF signaling drives myeloid-derived suppressor cell accumulation.

Authors:  Xueqiang Zhao; Lijie Rong; Xiaopu Zhao; Xiao Li; Xiaoman Liu; Jingjing Deng; Hao Wu; Xia Xu; Ulrike Erben; Peihua Wu; Uta Syrbe; Joachim Sieper; Zhihai Qin
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

7.  Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes.

Authors:  L Probert; J Keffer; P Corbella; H Cazlaris; E Patsavoudi; S Stephens; E Kaslaris; D Kioussis; G Kollias
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

Review 8.  The role of TNF superfamily members in T-cell function and diseases.

Authors:  Michael Croft
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

9.  Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha.

Authors:  S Yokota; T D Geppert; P E Lipsky
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

10.  Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.

Authors:  J S Andrews; A E Berger; C F Ware
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

View more
  81 in total

1.  TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells.

Authors:  Itay Raphael; Francisco Gomez-Rivera; Rebecca A Raphael; Rachel R Robinson; Saisha Nalawade; Thomas G Forsthuber
Journal:  JCI Insight       Date:  2019-12-19

2.  Neuroinflammation Induces Neurodegeneration.

Authors:  D Kempuraj; R Thangavel; P A Natteru; G P Selvakumar; D Saeed; H Zahoor; S Zaheer; S S Iyer; A Zaheer
Journal:  J Neurol Neurosurg Spine       Date:  2016-11-18

3.  Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profiles.

Authors:  Kelsey E Huntington; Anna Louie; Lanlan Zhou; Attila A Seyhan; Aaron Wp Maxwell; Wafik S El-Deiry
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

4.  Plasticity of Naturally Occurring Regulatory T Cells in Allergic Airway Disease Is Modulated by the Transcriptional Activity of Il-6.

Authors:  Morgan MacBeth; Anthony Joetham; Erwin W Gelfand; Michaela Schedel
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

5.  Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19.

Authors:  Sarah Adamo; Stéphane Chevrier; Carlo Cervia; Yves Zurbuchen; Miro E Raeber; Liliane Yang; Sujana Sivapatham; Andrea Jacobs; Esther Baechli; Alain Rudiger; Melina Stüssi-Helbling; Lars C Huber; Dominik J Schaer; Bernd Bodenmiller; Onur Boyman; Jakob Nilsson
Journal:  Allergy       Date:  2021-06-30       Impact factor: 14.710

6.  Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways.

Authors:  Ramin Sedaghat Herati; Luisa Victoria Silva; Laura A Vella; Alexander Muselman; Cecile Alanio; Bertram Bengsch; Raj K Kurupati; Senthil Kannan; Sasikanth Manne; Andrew V Kossenkov; David H Canaday; Susan A Doyle; Hildegund C J Ertl; Kenneth E Schmader; E John Wherry
Journal:  Cell Rep Med       Date:  2021-05-07

7.  Immunosuppression as a Hallmark of Critical COVID-19: Prospective Study.

Authors:  Elżbieta Kalicińska; Donata Szymczak; Aleksander Zińczuk; Barbara Adamik; Jakub Smiechowicz; Tomasz Skalec; Danuta Nowicka-Suszko; Monika Biernat; Aleksandra Bogucka-Fedorczuk; Justyna Rybka; Adrian Martuszewski; Waldemar Gozdzik; Krzysztof Simon; Tomasz Wróbel
Journal:  Cells       Date:  2021-05-23       Impact factor: 6.600

8.  GMI, an Immunomodulatory Peptide from Ganoderma microsporum, Restrains Periprosthetic Joint Infections via Modulating the Functions of Myeloid-Derived Suppressor Cells and Effector T Cells.

Authors:  Kuo-Ti Peng; Jiun-Liang Chen; Liang-Tseng Kuo; Pei-An Yu; Wei-Hsiu Hsu; Chiang-Wen Lee; Pey-Jium Chang; Tsung-Yu Huang
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

9.  Combined prenatal Lactobacillus reuteri and ω-3 supplementation synergistically modulates DNA methylation in neonatal T helper cells.

Authors:  Mika Gustafsson; Maria C Jenmalm; Johanna Huoman; David Martínez-Enguita; Elin Olsson; Jan Ernerudh; Lennart Nilsson; Karel Duchén
Journal:  Clin Epigenetics       Date:  2021-06-30       Impact factor: 6.551

10.  Characterization of microglial transcriptomes in the brain and spinal cord of mice in early and late experimental autoimmune encephalomyelitis using a RiboTag strategy.

Authors:  Shaona Acharjee; Paul M K Gordon; Benjamin H Lee; Justin Read; Matthew L Workentine; Keith A Sharkey; Quentin J Pittman
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.